Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential
(Q28210693)
scientific article (publication date: 2 May 2003)
scientific article (publication date: 2 May 2003)
Language:
other details
| description | scientific article (publication date: 2 May 2003) |
External Links
| (P356) |
10.1074/JBC.M300387200
|
| (P698) |
12595526
|